Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity.
Peclat TR, Agorrody G, Colman L, Kashyap S, Zeidler JD, Chini CCS, Warner GM, Thompson KL, Dalvi P, Beckedorff F, Ebtehaj S, Herrmann J, van Schooten W, Chini EN.
Peclat TR, et al. Among authors: chini ccs.
Cardiovasc Res. 2024 Mar 14;120(3):286-300. doi: 10.1093/cvr/cvae025.
Cardiovasc Res. 2024.
PMID: 38271281